COMPARISON OF METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN IDENTIFYING CARDIOVASCULAR RISK IN CHINESE INDIVIDUALS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Zou, Y. W. [1 ]
Li, Q. H. [1 ]
Gao, J. W. [2 ]
Pan, J. [1 ]
Ma, J. D. [1 ]
Chen, L. F. [1 ]
Lin, J. [1 ]
Mo, Y. [1 ]
Zhang, X. [1 ]
Liu, P. M. [2 ]
Dai, L. [1 ]
机构：
[1] Sun Yat Sen Univ, Sun Yat sen Mem Hosp, Dept Rheumatol, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Sun Yat sen Mem Hosp, Dept Cardiol, Guangzhou, Peoples R China
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.2999
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0276
引用
收藏
页码：1264 / 1264
页数：1
相关论文
共 50 条
  • [1] Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
    Jung, Han Na
    Jung, Chang Hee
    [J]. DIABETES & METABOLISM JOURNAL, 2023, 47 (02) : 198 - 200
  • [2] Comparison of Outcomes Between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-alcoholic Fatty Liver Disease: A Meta-Analysis
    Virk, Ghazala S.
    Vajje, Jaahnavi
    Virk, Nausheen K.
    Mannam, Raam
    Rehman, Wajeeh
    Ghobriel, Naglaa G.
    Mian, Irfan-ud-din
    Usama, Muhammad
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (08)
  • [3] Metabolic dysfunction-associated fatty liver disease reflects a significantly higher risk of hypertension than non-alcoholic fatty liver disease
    Tatsuki Uehara
    Hiromichi Wakui
    Kouichi Tamura
    [J]. Hypertension Research, 2023, 46 : 1165 - 1167
  • [4] METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE IS ASSOCIATED WITH SUBCLINICAL ATHEROSCLEROSIS MORE THAN NON-ALCOHOLIC FATTY LIVER DISEASE
    Park, Jung Gil
    Jang, Jaeyoung
    Lee, Yu Rim
    Kang, Min Kyu
    Jang, Se Young
    Kweon, Young-Oh
    Tak, Won Young
    Park, Soo Young
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S1212 - S1212
  • [5] Metabolic dysfunction-associated fatty liver disease reflects a significantly higher risk of hypertension than non-alcoholic fatty liver disease
    Uehara, Tatsuki
    Wakui, Hiromichi
    Tamura, Kouichi
    [J]. HYPERTENSION RESEARCH, 2023, 46 (05) : 1165 - 1167
  • [6] Non-alcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease: Conceptual changes for clinicians, researchers and patients
    Lin, Shuang Zhe
    Chen, Yuan Wen
    Fan, Jian Gao
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2020, 21 (11) : 604 - 609
  • [7] Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease
    Chun, Ho Soo
    Lee, Minjong
    Lee, Jae Seung
    Lee, Hye Won
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Lee, Yong-Ho
    Kim, Ji-Hye
    Kim, Seung Up
    [J]. LIVER INTERNATIONAL, 2023, 43 (03) : 608 - 625
  • [8] Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease
    Colaci, Carmen
    Gambardella, Maria Luisa
    Scarlata, Giuseppe Guido Maria
    Boccuto, Luigi
    Colica, Carmela
    Luzza, Francesco
    Scarpellini, Emidio
    Mendez-Sanchez, Nahum
    Abenavoli, Ludovico
    [J]. HEPATOMA RESEARCH, 2024, 10
  • [9] Comparative effects of non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease on risk of incident cardiovascular events: a meta-analysis of about 13 million individuals
    Mantovani, Alessandro
    Csermely, Alessandro
    Tilg, Herbert
    Byrne, Christopher D.
    Targher, Giovanni
    [J]. GUT, 2023, 72 (07) : 1433 - 1436
  • [10] Metabolic dysfunction-associated fatty liver disease (MAFLD) and non-alcoholic fatty liver disease (NAFLD): distinct fatty liver entities with different clinical outcomes?
    Kaya, Eda
    Zedginidze, Aleko
    Bechmann, Lars
    Canbay, Ali
    [J]. HEPATOBILIARY SURGERY AND NUTRITION, 2022, 11 (02) : 299 - 301
12345